Eli Lilly holds the lead position in the weight management market right now. But Viking Therapeutics is working on a ...

Since then, supply has returned thanks to Lilly's investments in manufacturing and a move to also offer Zepbound, previously ...

In the closing of the recent trading day, Viking Therapeutics, Inc. (VKTX) stood at $33.54, denoting a -3.44% move from the preceding trading day.

Viking Therapeutics, Inc. (NASDAQ:VKTX) is one of the best healthcare stocks with the highest upside. Viking Therapeutics, ...

Viking offers asymmetric upside in GLP-1 drugs with positive trial data, strong cash, and buyout potential despite biotech ...

Viking’s newly announced 2027-28 deployment includes six ships operating winter itineraries in Europe. Nearly half of the ...

Pfizer has agreed to acquire Metsera, a company specializing in weight-loss medications, for $47.50 per share in cash, along ...

It's autumn, and it's time to pull on your market and fall festival boots. Opportunities await to enjoy food, music and ...

Eli Lilly (LLY), the world’s highest-valued pharmaceutical company by market capitalization, holds a leading position in the ...

Across the recent three months, 10 analysts have shared their insights on Viking Holdings (NYSE: VIK ), expressing a variety of opinions spanning from bullish to bearish. In the table below, you'll ...

A larger pharma company may decide it's worth taking Viking's promising drug candidate through phase 3.

Parc Astérix is once again celebrating the magic of Christmas during the Christmas holidays, from December 20, 2025, to ...